SN.LSE Smith & Nephew PLC

Healthcare Health Care Equipment & Supplies London Exchange
11.13 GBX
Close of Nov 3, 2026
979.32 1,360
Market cap
GBX 9.31B
P/E
20.2x
P/B
2.39x
ROE
23.1%
Dividend yield
2.66%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is SN.LSE undervalued?

Graham number
Price11.13
Graham value7.58
Premium46.7%

SN.LSE trades 46.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Smith & Nephew PLC fundamental analysis

No fundamental analysis for Smith & Nephew PLC yet.

Smith & Nephew PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used i…

Full company profile